Europe IVD Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe In Vitro Diagnostics (IVD) Market Analysis

The European in-vitro diagnostics market is expected to register a CAGR of 5.5% over the forecast period.

COVID-19 has significantly impacted supply-demand in the in-vitro diagnostics market in Europe as it was one of the severely affected regions. Increased number of in-vitro diagnostics testing for the diagnosis of COVID-19 symptoms augmented the adoption rate of these instruments. For instance, according to a report by the Gov.UK, almost 7.6 million lateral flow device tests were performed between 8 April and 21 April 2021 in England. This high volume of in-vitro diagnostic (IVD) tests in Europe for the precise diagnostics of COVID symptoms augmented the market's growth during the pandemic. However, the market growth remained stable during the post-pandemic period in Europe due to the reduced demand for COVID-19 in-vitro diagnostic testing and decreased confirmed cases in the region.

One of the major factors fueling market growth is the rising prevalence of chronic diseases throughout Europe. An increasing number of patients suffering from chronic diseases, including cancer, cardiovascular diseases, diabetes, and others, is augmenting the demand for early diagnosis. Further, the rising prevalence of several infectious diseases, such as influenza, tuberculosis, hepatitis, and others, is also fueling the demand for in-vitro diagnostics tests. For instance, according to European Centre for Disease Prevention and Control (ECDC), the number of reported influenza cases in Europe was 4,690 in the 2021-2022 season, significantly higher than the previous year. Also, according to data from International Diabetes Federation in 2021, the prevalence of diabetes among adults in Europe in 2021 was 9.2%, which was anticipated to increase to 9.8% by 2030. This increasing patient pool is growing the demand for precise diagnostics techniques, including molecular diagnostics, immunodiagnostics, and others, for specific outcomes, early detection, and reducing the rate of false positives during diagnostic procedures, which drive the demand for advanced in-vitro diagnostics products in Europe.

Further, the launch of advanced point-of-care testing kits for different indications, which are simple to use and highly efficient, is expected to boost the adoption of in-vitro diagnostics products in the region, thereby fuelling growth in the market. For instance, in July 2021, QuantuMDx Group Ltd. launched Q-POC in Europe to offer precise and rapid results for SARS-COV-2 within 30 minutes.

The increasing number of initiatives for the awareness of chronic diseases also increases the demand and adoption rate of in-vitro diagnostics tests for early detection. For instance, in August 2022, NHS organized a lung cancer awareness campaign to increase disease awareness and the importance of early detection through the available diagnostic procedures.

Therefore, owing to the high burden of chronic and infectious diseases, the launch of advanced products, and growing awareness, the demand for in-vitro diagnostics (IVD) products is expected to increase in Europe over the forecast period. However, stringent regulations and cumbersome reimbursement procedures will restrain the market's growth.

Europe In Vitro Diagnostics (IVD) Market Trends

The Instrument Segment is Expected to Hold a Major Share in the Market

Europe In Vitro Diagnostics (IVD) Industry Segmentation

As per the scope of this report, in-vitro diagnostics are the tests performed in laboratories or by consumers at home to diagnose, monitor, screen, and assess various diseases, conditions, or infections. IVD products are reagents, instruments, and systems intended for use in diagnosing diseases or other conditions. IVDs form an essential part of the current healthcare system. They reduce hospital stays and the need to recuperate. The Europe In-Vitro Diagnostics Market is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users) and Geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.